OBJECTIVE: The objective of the study was to quantitatively characterize peripheral tissue microvascular oxygenation during emergency department (ED) treatment of acute heart failure (HF). METHODS: This prospective, observational study enrolled acutely decompensated HF patients presenting to an urban ED and stable, asymptomatic HF patients evaluated in an outpatient cardiology clinic. Stable, pre-ED treatment, and post-ED treatment microvascular oxygen extraction ratios (OER(M)s) were calculated, defined as SaO(2) - StO(2)/0.8*SaO(2), where SaO(2) is pulse oximetry-derived arterial hemoglobin saturation and StO(2) is the tissue hemoglobin oxygen saturation measured with differential absorption spectroscopy. The OER(M) measurements were analyzed using repeated-measures analysis of variance. Pulse oximetry, patient demographics, HF etiology, serum B-type natriuretic peptide, and hemoglobin were measured along with a visual analogue scale to assess patient baseline characteristics and response to ED treatment (P < .05 was considered significant for all testing). RESULTS: The OER(M) for the stable HF group (n = 45) was 0.65 (SE = 0.07). The pre- and posttreatment OER(M)s for the ED HF group (n = 46) were 0.92 (SE = 0.07) and 0.75 (SE = 0.06), respectively. Whereas the pretreatment ED OER(M) was higher than the stable patient OER(M) (P = .001), the posttreatment ED OER(M) was not significantly different from the stable patient measurement (P = .271). CONCLUSIONS: Oxygen extraction in acute HF is significantly increased, but approaches values found in the stable HF population after ED treatment. The OER(M) may deserve closer examination as a possible goal-directed variable in the treatment of acute HF.
OBJECTIVE: The objective of the study was to quantitatively characterize peripheral tissue microvascular oxygenation during emergency department (ED) treatment of acute heart failure (HF). METHODS: This prospective, observational study enrolled acutely decompensated HF patients presenting to an urban ED and stable, asymptomatic HF patients evaluated in an outpatient cardiology clinic. Stable, pre-ED treatment, and post-ED treatment microvascular oxygen extraction ratios (OER(M)s) were calculated, defined as SaO(2) - StO(2)/0.8*SaO(2), where SaO(2) is pulse oximetry-derived arterial hemoglobin saturation and StO(2) is the tissue hemoglobin oxygen saturation measured with differential absorption spectroscopy. The OER(M) measurements were analyzed using repeated-measures analysis of variance. Pulse oximetry, patient demographics, HF etiology, serum B-type natriuretic peptide, and hemoglobin were measured along with a visual analogue scale to assess patient baseline characteristics and response to ED treatment (P < .05 was considered significant for all testing). RESULTS: The OER(M) for the stable HF group (n = 45) was 0.65 (SE = 0.07). The pre- and posttreatment OER(M)s for the ED HF group (n = 46) were 0.92 (SE = 0.07) and 0.75 (SE = 0.06), respectively. Whereas the pretreatment ED OER(M) was higher than the stable patient OER(M) (P = .001), the posttreatment ED OER(M) was not significantly different from the stable patient measurement (P = .271). CONCLUSIONS:Oxygen extraction in acute HF is significantly increased, but approaches values found in the stable HF population after ED treatment. The OER(M) may deserve closer examination as a possible goal-directed variable in the treatment of acute HF.
Authors: Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn Journal: N Engl J Med Date: 2004-11-08 Impact factor: 91.245
Authors: Mihai Gheorghiade; Ferenc Follath; Piotr Ponikowski; Jeffrey H Barsuk; John E A Blair; John G Cleland; Kenneth Dickstein; Mark H Drazner; Gregg C Fonarow; Tiny Jaarsma; Guillaume Jondeau; Jose Lopez Sendon; Alexander Mebazaa; Marco Metra; Markku Nieminen; Peter S Pang; Petar Seferovic; Lynne W Stevenson; Dirk J van Veldhuisen; Faiez Zannad; Stefan D Anker; Andrew Rhodes; John J V McMurray; Gerasimos Filippatos Journal: Eur J Heart Fail Date: 2010-03-30 Impact factor: 15.534
Authors: D S Ander; M Jaggi; E Rivers; M Y Rady; T B Levine; A B Levine; J Masura; M Gryzbowski Journal: Am J Cardiol Date: 1998-10-01 Impact factor: 2.778